Genmab A (GMAB) EBT Margin (2018 - 2026)

Genmab A has reported EBT Margin for 6 years, with the latest figure at 8.26% in Q1 2026.

• For the quarter ending Q1 2026, EBT Margin fell 2587.0% year-over-year to 8.26%; the trailing twelve-month figure through Mar 2026 stood at 34.37% (down 178.0% YoY), and the FY2025 full-year result was 32.37%, down 1012.0% from the prior year.
• EBT Margin for Q1 2026 stood at 8.26%, down from 47.16% in the prior quarter.
• The five-year high for EBT Margin was 47.16% in Q3 2025, with the low at 8.26% in Q1 2026.
• Historically, EBT Margin has averaged 35.28% across 3 years, with a median of 39.41% in 2024.
• Annual changes were most pronounced in 2025 — EBT Margin jumped 1616 bps — and 2026, when it slumped 2587 bps.
• Genmab A's EBT Margin stood at 31.0% in 2024, then jumped by 52 bps to 47.16% in 2025, then sank by 82 bps to 8.26% in 2026.
• The last three EBT Margin figures came in at 8.26% (Q1 2026), 47.16% (Q3 2025), and 45.73% (Q2 2025), per Business Quant data.